Zoekresultaten - 4 results
Utilization of gabapentin by people in treatment for substance use disorders in Belgium (2011-2014): a cross-sectional study.
bought gabapentin in a time span that could indicate consumption at a dose that exceeded the maximum approved dose of 3600 mg/day. Methods: This analysis is the result of an observational cross-sectional ...
General practice patients treated for substance use problems: a cross-national observational study in Belgium.
substance-related problems; (ii) the profile and the magnitude of the patient population that is treated for substance use problems. METHODS: Observational study by the Belgian Network of Sentinel General Practices ...
Treatment for substance use disorders: the Belgian Treatment Demand Indicator registration protocol.
participating in this data collection since then. METHODS / DESIGN: This surveillance register collects information on every treatment episode started by patients for their substance use disorder. Information is ...
Health care trajectories and medication consumption of substance users in treatment: linking TDI and IMA databases (Belgium)
Publication Type: Scientific poster, presentation or proceeding Authors: Karin De Ridder; Jérôme Antoine; L. Gremeaux; E Plettinckx; Peter Blanckaert; Jean Tafforeau Source: Methods in Epidemiology ...